Global In Vitro Diagnostic Market Analysis

Global In Vitro Diagnostic Market Analysis

The In Vitro Diagnostics (IVD) Industry represents one of the most lucrative segments in global healthcare industry. The size of the global IVD market was in excess of US$ 38 Billion in 2007. ropelled by factors such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient awareness he IVD market is particularly characterized by the emergence of various novel technologies; with Molecular diagnostics and point of care tests expected to play a very important role in driving the future growth of the industry, says “Global In Vitro Diagnostic Market Analysis”, a market research report by RNCOS.

The elaborative research provides a complete overview on the global IVD market and provides a detailed analysis on both the traditional IVD testing markets as well as the emerging technologies. Analysis and statistics regarding market size, growth, share, segmentation and geographic distribution, as well as key drivers, restraints and trends in technology development have been thoroughly analyzed to give a comprehensive overview.

Key Findings

• The global IVD market is forecasted to grow at a CAGR 6.72% from 2007 to 2012.
  
  
• Point of care diagnostics presently accounts for the largest share in the global IVD market and is expected to jump to nearly US$ 18 Billion by 2012.
  
  
• Molecular diagnostics with a CAGR growth of 15.4% represents the fastest growing IVD segment.
  
  
• North America, Europe and Japan together accounted for 90% of the global IVD market in 2007. However IVD markets in emerging economies such as India, China and Brazil s are expected to witness strong growth in the future.
  
  
• The top three IVD layers together account for more than one-third of the global IVD market.
  
  
• With over 33 Million people living with HIV, the market for HIV diagnostics is expected to undergo strong growth in the next five years.
  
  
• High R&D costs and short product lifecycles is a major challenge faced by IVD manufacturers.

Key Issues

• What is the current scenario of the global IVD market?
  
  
• What are the emerging trends and technologies in the global IVD market?
  
  
• What are the driving and restraining factors of the global IVD market?
  
  
• What are the opportunities emerging for various segments in the global IVD market?
  
  
• Which are the emerging IVD markets?
  
  
• Who are the key players in the global IVD market?

Key Players Analyzed

This section provides the overview, key facts and financial information of prominent players in the Global IVD market like Roche Holding Ltd., Abbott Laboratories, Siemens AG, Beckman CoulterInc and Ortho-Clinical Diagnostics.

Research Methodology

Information Sources
Information has been sourced from books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.  
 

1. Analyst View

2. In Vitro Diagnostic Market Overview

2.1 Introduction

2.2 What is In Vitro Diagnostics?

2.3 Market Size & Growth

2.4 Market Share of Top Players

3. Market Drivers

3.1 Chronic & Infectious Diseases

3.2 New Technologies

3.3 Emerging Markets

3.4 Diversifying Applications

3.5 Healthcare Infrastructure

4. Clinical Segmentation (Current & Future Scenario - 2012)

4.1 Point of Care Diagnostics

4.2 Clinical Chemistry

4.3 Immunochemistry

4.4 Hematology

4.5 Molecular Diagnostics

4.6 Microbiology

4.7 Coagulation

4.8 Pathology

4.9 Blood Screen Immunoassays

4.10 Immunohematology

5. Segmentation by Indication (Current & Future Scenario - 2012)

5.1 Diabetes

5.2 Cardiovascular

5.3 Cancer

5.4 HIV

5.5 Tuberculosis

6. Geographical Segmentation (Current & Future Scenario - 2012)

6.1 North America

6.1.1 United States

6.1.2 Canada

6.2 Europe

6.2.1 Germany

6.2.2 France

6.2.3 Italy

6.2.4 United Kingdom

6.2.5 Spain

6.2.6 Other European Countries

6.3 Japan

6.4 Rest of the World

6.4.1 China

6.4.2 South Korea

6.4.3 India

6.4.4 Turkey

6.4.5 Brazil

6.4.6 Mexico

7. Roadblocks

7.1 Regulatory & Reimbursement Issues

7.2 R&D & Short Product Lifecycle

7.3 Awareness

8. Key Player Profiles

8.1 Roche Holding Ltd.

8.2 Abbott Laboratories

8.3 Siemens AG

8.4 Beckman Coulter, Inc.

8.5 Ortho-Clinical Diagnostics

List of Figures:

Figure 2-1: Global - In Vitro Diagnostic Market (in Billion US$), 2006 & 2007E

Figure 2-2: Global - Forecast for In Vitro Diagnostic Market (in Billion US$), 2008-2012

Figure 2-3: Global - In Vitro Diagnostic Market* by Player (%), 2007

Figure 4-1: Global - In Vitro Diagnostic Market by Clinical Segment (in Billion US$), 2007E

Figure 4-2: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2007E

Figure 4-3: Global - CAGR Growth of In Vitro Diagnostic Market by Clinical Segment (%), 2007 to 2012

Figure 4-4: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (in Billion US$), 2012

Figure 4-5: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2012

Figure 4-6: Point of Care Blood Testing vs Pathology Lab Testing

Figure 4-7: Global - Point of Care Diagnostic Market* (in Billion US$), 2005-2007E

Figure 4-8: Global - Point of Care Diagnostic Market by Segment (%), 2007E

Figure 4-9: Global - Point of Care Diagnostic Market by Application (%), 2005

Figure 4-10: Global - Forecast for Point of Care Diagnostic Market* (in Billion US$), 2008-2012

Figure 4-11: Global - Clinical Chemistry Market (in Billion US$), 2006 & 2007E

Figure 4-12: Global - Forecast for Clinical Chemistry Market (in Billion US$), 2008-2012

Figure 4-13: Global - Immunochemistry Market (in Billion US$), 2006 & 2007E

Figure 4-14: Global - Clinical Chemistry & Immunochemistry Market by Player (%), 2007

Figure 4-15: Global - Forecast for Immunochemistry Market (in Billion US$), 2008-2012

Figure 4-16: Global - Hematology Market* (in Billion US$), 2006 & 2007E

Figure 4-17: Global - Forecast for Hematology Market* (in Billion US$), 2008-2012

Figure 4-18: Global - Molecular Diagnostic Market* (in Billion US$), 2006 & 2007E

Figure 4-19: Global - Molecular Diagnostic Market by Player (%), 2007

Figure 4-20: Global - Molecular Diagnostic Market by Segment (%), 2007E

Figure 4-21: Global - Forecast for Molecular Diagnostic Market* (in Billion US$), 2008-2012

Figure 4-22: Global - Microbiology Diagnostic Market (in Billion US$), 2006 & 2007E

Figure 4-23: Global - Forecast for Microbiology Diagnostic Market (in Billion US$), 2008-2012

Figure 4-24: Global - Coagulation Diagnostic Market (in Billion US$), 2006 & 2007E

Figure 4-25: Global - Forecast for Coagulation Diagnostic Market (in Billion US$), 2008-2012

Figure 4-26: Global - Pathology Diagnostic Market (in Billion US$), 2006 & 2007E

Figure 4-27: Global - Forecast for Pathology Diagnostic Market (in Billion US$), 2008-2012

Figure 4-28: Global - Blood Screen Immunoassays Market (in Billion US$), 2006 & 2007E

Figure 4-29: Global - Forecast for Blood Screen Immunoassays Market (in Billion US$), 2008-2012

Figure 4-30: Global - Immunohematology Diagnostic Market (in Billion US$), 2006 & 2007E

Figure 4-31: Global - Forecast for Immunohematology Diagnostic Market (in Billion US$), 2008-2012

Figure 5-1: Global - Diabetic Population (in Million), 2007 & 2025F

Figure 5-2: Global - Blood Glucose Monitoring Market (in Billion US$), 2005-2007E

Figure 5-3: Global - Blood Glucose Monitoring Market by Player (%), 2005

Figure 5-4: Global - Forecast for Blood Glucose Monitoring Market (in Billion US$), 2008-2012

Figure 5-5: Global - Forecast for Cardiovascular Diagnostic Market (in Billion US$), 2008-2012

Figure 5-6: Global - Cancer Diagnostic Market (in Million US$), 2006E & 2012F

Figure 5-7: Global - HIV Diagnostic & Monitoring Market (in Million US$), 2004, 2007E & 2012F

Figure 5-8: Global - Tuberculosis Diagnostic Market by Segment (%), 2005

Figure 5-9: Global - Tuberculosis Detection & Monitoring Market by Segment (%), 2005

Figure 6-1: Global - In Vitro Diagnostic Market by Region (%), 2007E

Figure 6-2: Global - Forecast for In Vitro Diagnostic Market by Region (%), 2012

Figure 6-3: US - In Vitro Diagnostic Market (in Billion US$), 2006 & 2007E

Figure 6-4: US - In Vitro Diagnostic Market* by Segment (%), 2007E

Figure 6-5: US - Forecast for In Vitro Diagnostic Market (in Billion US$), 2008-2012

Figure 6-6: Canada - In Vitro Diagnostic Market (in Million US$), 2004 & 2007E

Figure 6-7: Canada - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-8: Europe - In Vitro Diagnostic Market (in Million US$), 2006 & 2007E

Figure 6-9: Europe - In Vitro Diagnostic Market by Country (%), 2007E

Figure 6-10: Europe - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-11: Germany - In Vitro Diagnostic Market (in Million US$), 2005-2007E

Figure 6-12: Germany - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-13: France - In Vitro Diagnostic Market (in Million US$), 2006 & 2007E

Figure 6-14: France - In Vitro Diagnostic Reagents Market by Segment (%), 2005

Figure 6-15: France - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-16: Italy - In Vitro Diagnostic Market (in Million US$), 2005-2007E

Figure 6-17: Italy - In Vitro Diagnostic Market by Segment (%), 2005

Figure 6-18: Italy - In Vitro Diagnostic Reagents Market by Segment (%), 2005

Figure 6-19: Italy - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-20: UK - In Vitro Diagnostic Market (in Million US$), 2005-2007E

Figure 6-21: UK - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-22: Spain - In Vitro Diagnostic Market (in Million US$), 2004, 2006 & 2007E

Figure 6-23: Spain - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-24: Japan - In Vitro Diagnostic Market (in Million US$), 2006 & 2007E

Figure 6-25: Japan - In Vitro Diagnostic Market by Player (%), 2004

Figure 6-26: Japan - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-27: China - In Vitro Diagnostic Market (in Million US$), 1995, 2004 & 2007E

Figure 6-28: China - In Vitro Diagnostic Market by Segment (%), 2004

Figure 6-29: China - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-30: South Korea - In Vitro Diagnostic Market* (in Million US$), 2004 & 2007

Figure 6-31: South Korea - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-32: India - In Vitro Diagnostic Market* (in Million US$), 2006 & 2007

Figure 6-33: India - In Vitro Diagnostic Market* by Segment (%), 2006E

Figure 6-34: India - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-35: Turkey - In Vitro Diagnostic Market (in Million US$), 2006 & 2007E

Figure 6-36: Turkey - Share* of Clinical Laboratories by Type (%), 2004

Figure 6-37: Turkey - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-38: Brazil - In Vitro Diagnostic Market (in Million US$), 1995 & 2007E

Figure 6-39: Brazil - In Vitro Diagnostic Market* by Segment (%), 2007E

Figure 6-40: Brazil - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 6-41: Mexico - In Vitro Diagnostic Market (in Million US$), 1995 & 2007E

Figure 6-42: Mexico - In Vitro Diagnostic Market* by Segment (%), 2007E

Figure 6-43: Mexico - Forecast for In Vitro Diagnostic Market (in Million US$), 2008-2012

Figure 7-1: Global - R&D Expenditure by In Vitro Diagnostic vs Other Industrial Sectors (%), 2003

List of Tables:

Table 2-1: Commonly Used In Vitro & In Vivo Diagnostic Tests

Table 4-1: Global - Top Players in Clinical Chemistry Market (2006)

Table 4-2: Global - Top Players in Immunochemistry Market (2006)

Table 4-3: Global - Top Players in Microbiology Diagnostic Market (2006)

Table 4-4: Global - Top Players in Coagulation Diagnostic Market (2006)

Table 5-1: Global - Cancer Diagnostic Market by Type (in Million US$), 2002-2006E

Table 6-1: Germany - In Vitro Diagnostic Market by Segment (in Million US$), 2004E

Table 6-2: Other European Countries - In Vitro Diagnostic Market (in Million US$), 2006

Table 6-3: Japan - In Vitro Diagnostic Market by Segment (%), 2000, 2004 & 2007E

Table 6-4: South Korea - In Vitro Diagnostic Market by Segment (in Million US$), 2004E

Table 8-1: Roche Holding Ltd. - Key Financials (in Million US$), 2004-2006

Table 8-2: Abbott Laboratories - Key Financials (in Million US$), 2005-2007

Table 8-3: Siemens AG - Key Financials (in Million US$), 2005-2007

Table 8-4: Beckman Coulter, Inc. - Key Financials (in Million US$), 2005-2007